病毒诱导的APOBEC3转变发生在膀癌开始时
George H Hatton1, Sally R James2, Andrew S Mason1
1Jack Birch Unit for Molecular Carcinogenesis, Department of Biology and York Biomedical Research Institute, University of York, Heslington, York, UK.
Science advances
|December 3, 2025
概括
乙基多瘤病毒 (BKPyV) 感染触发了尿路细胞中的APOBEC3酶活性,导致导致导致膀癌的突变. 这种"转基因变异"表明尿路细胞癌可能可以通过抗病毒疗法预防.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 遗传学 遗传学 是一个
背景情况:
- 人类尿中的致癌包括来自APOBEC3酶的高突变负担,但病毒原因尚未确立.
- 乙基多瘤病毒 (BKPyV) 是一种常见的病毒,在脏中持续存在,在尿液中检测到,可能与泌尿器变化有关.
研究的目的:
- 研究BKPyV感染在诱导APOBEC3表达和随后的尿路细胞癌发生中的作用.
- 探索"转变异性"的机制,即旁观者细胞因附近的病毒感染而获得突变.
主要方法:
- 在正常人尿膜模型中诱导慢性BKPyV感染.
- 对先天免疫反应的分析,包括细胞挤出和干扰素信号传递.
- 在受感染和旁观者细胞中评估APOBEC3表达和突变特征.
主要成果:
- BKPyV感染诱导了细胞挤出和膜干扰素信号传递的先天反应,增加了APOBEC3的表达.
- 感染细胞和旁观者细胞中的APOBEC3活性产生了突变特征,反映了肌肉侵入性膀癌中的突变特征.
- 在BKPyV感染附近的未感染的旁观者细胞获得了APOBEC3驱动的突变,获得了超变的优势.
结论:
- BKPyV感染可以通过诱导APOBEC3介导的突变在受感染和旁观者细胞通过"转基因变异".
- 这种机制解释了病毒阴性,富含APOBEC3的尿路细胞癌,这表明通过抗病毒干预可以预防.
相关概念视频
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Spontaneous and Induced Mutations
2.0K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.0K
Mutations
94.3K
Overview
94.3K


